Article ID Journal Published Year Pages File Type
5825627 Clinical Therapeutics 2013 11 Pages PDF
Abstract
These findings suggest that the test formulation of lamivudine 100 mg meets the FDA regulatory standards for bioequivalence with the reference formulation. Both formulations were well tolerated.
Related Topics
Health Sciences Medicine and Dentistry Medicine and Dentistry (General)
Authors
, , , , , , , ,